PubMed · 1989 · 55 citations · 0 references
MedicineOncologySurgeryBreast OncologyOncologic SurgerySurgical OncologyBlood Loss ManagementBlood Transfusion ManagementBreast Cancer SurgeryBreast SurgeryPerioperative Blood ManagementTransfusion SupportBlood Transfusion TherapyPerioperative Blood Loss ManagementPerioperative Blood Transfusion ManagementPerioperative Red Cell TransfusionPostoperative Transfusion Management
The effect of perioperative blood transfusion on disease-free and overall survival was studied in 812 patients with stages I and II breast cancer, followed up prospectively in a multicenter study. All patients initially underwent a modified radical mastectomy. Patients with axillary node-negative, stage I cancer were followed up without additional therapy. Patients with axillary node-positive, stage II cancer were randomized to receive adjuvant chemoendocrine therapy. Transfusion was done in 35.8% of the patients with stage I and in 37.3% of the patients with stage II cancer. For the patients with stage II cancer, perioperative blood transfusion did not affect disease-free or overall survival. For the patients with stage I cancer, perioperative blood transfusion resulted in a worse disease-free and overall survival (p = 0.05 and 0.02, respectively), which was particularly evident for those patients who received more than 1 unit. This study suggests that stage of disease, adjuvant therapy, number of transfusions, and duration of follow-up must be considered in further analyses.